Page last updated: 2024-10-23

betaxolol and Hemolysis

betaxolol has been researched along with Hemolysis in 2 studies

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Liu, H3
Han, X1
Li, H1
Tao, Q1
Hu, J1
Liu, S1
Zhou, J1
Li, W1
Yang, F1
Ping, Q1
Wei, S1
Lin, H1
Hou, D1
Aoyagi, S1
Fukunaga, S1
Tayama, E1
Nakamura, E1
Egawa, N1
Hosokawa, Y1

Other Studies

2 other studies available for betaxolol and Hemolysis

ArticleYear
Wettability and contact angle affect precorneal retention and pharmacodynamic behavior of microspheres.
    Drug delivery, 2021, Volume: 28, Issue:1

    Topics: Animals; Bentonite; Betaxolol; Cell Survival; Chemistry, Pharmaceutical; Delayed-Action Preparations

2021
Benefits of a beta-blocker for intractable hemolysis due to paraprosthetic leakage.
    Asian cardiovascular & thoracic annals, 2007, Volume: 15, Issue:5

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Anemia, Hemolytic; Aspartate Aminotransferases; B

2007